Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06441487 · ClinicalTrials.gov registry record · NA

mPATH-Cloud for Colorectal Cancer Screening

A NA study of Colorectal Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
1,000
Enrollment target
2
Study locations

NCT06441487: Recruiting NA study of Colorectal Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT06441487 is a NA study of Colorectal Cancer that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 1,000 participants, below the 1,542-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (35% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06441487, a NA study of Colorectal Cancer, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
2
Study locations

Study Summary

This study assesses the effectiveness of colorectal cancer (CRC) screening intervention, mobile Patient Technology for Health (mPATH™-Cloud), compared to usual care among subjects who are overdue for CRC screening according to recommendations of the United States Preventive Services Taskforce (USPSTF). The trial randomly selects and enrolls 1,000 eligible subjects served by one federally qualified health center (FQHC) in North Carolina. Subjects are randomized to two study arms, Usual Care (Arm 1) or Mobile Health Decision Support (Arm 2). Usual care consists of a visit-based screening recommendation to complete a stool test (e.g., FOBT, FIT, Cologuard) or referral to a screening colonoscopy. Subjects randomized to the Mobile Health Decision Support (Arm 2) are sent a message by text or US mail, depending on their preferred communication mode as indicated in the electronic health record (EHR), to visit the mPATH™-Cloud website. Subjects who engage with mPATH™-Cloud are invited to answer brief questions to confirm their eligibility and then view a short decision aid video designed to help people choose the CRC screening test (FIT or colonoscopy) that they would like to receive. After watching the video, subjects can choose a CRC screening test. Their primary care provider at the FQHC orders the appropriate test and, where indicated, refers the subjects to a colonoscopy. Subjects who request FIT screening and subjects who do not select any test receive a FIT mailed to their home address. The primary outcome of interest is CRC screening completion within 6 months after randomization as assessed by EHR chart review. A completed screening is any of the following: colonoscopy completion (regardless of indication); 2) at least one FIT test with a normal result; or diagnostic colonoscopy following an abnormal FIT result. We hypothesize that we will observe a higher CRC screening completion rate in the Mobile Health Decision Support intervention arm (Arm 2). This study in

Primary Outcome

The proportion of individuals who completed CRC screening using any of the screening modalities recommended by the United States Preventive Service Task Force. Screening modalities could be fecal occult blood test (FIT), fecal occult blood test (FOBT), the stool DNA test combines the FIT ( FIT-DNA), colonoscopy, flexible sigmoidoscopy, flexible sigmoidoscopy with FIT, Computerized Tomography (CT) colonography.

Conditions Studied

Interventions

  • BEHAVIORAL Usual care
  • BEHAVIORAL Mobile Health Decision Support

Study Locations (2)

North Carolina

  • Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill - Chapel Hill
  • Wake Forest University - Winston-Salem

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2025-06-24
Est. Completion 2029-01-01
Phase NA

What NCT06441487 shows while recruiting

NCT06441487 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, below the 1,542-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (35% lower).

The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.

NCT06441487 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06441487 about?

NCT06441487 is a clinical study titled "mPATH-Cloud for Colorectal Cancer Screening". This study assesses the effectiveness of colorectal cancer (CRC) screening intervention, mobile Patient Technology for Health (mPATH™-Cloud), compared to usual care among subjects who are overdue for CRC screening according to recommendations of the United States Preventive Services Taskforce (USPST...

What is the current status of trial NCT06441487?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-06-24. Estimated completion is 2029-01-01.

What conditions does trial NCT06441487 study?

This clinical trial studies the following conditions: Colorectal Cancer.

What interventions are being tested in trial NCT06441487?

The interventions under investigation include: Usual care (BEHAVIORAL), Mobile Health Decision Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT06441487?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06441487 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06441487's enrollment target sits among peer trials

1,000 47th of 381 higher than 331 of 381 other Colorectal Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06441487, the US trial registry maintained by the National Library of Medicine. NCT06441487 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.